tiprankstipranks
Ligand provides updated five-year outlook
The Fly

Ligand provides updated five-year outlook

Long-term royalty receipts expected to deliver at least a 22% compound annual growth rate, or CAGR. Existing commercial programs and late-stage pipeline support royalty revenue CAGR of 18%. Total royalty receipts of approximately $285M in 2029.

Don't Miss Our New Year's Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App